{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T18:03:40Z","timestamp":1785866620021,"version":"3.56.0"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"supplement4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hypertension"],"published-print":{"date-parts":[[1995,12]]},"DOI":"10.1097\/00004872-199512002-00002","type":"journal-article","created":{"date-parts":[[2006,10,4]],"date-time":"2006-10-04T05:12:02Z","timestamp":1159938722000},"page":"s5-s9","source":"Crossref","is-referenced-by-count":10,"title":["Assessing the safety profile of a new antihypertensive agent"],"prefix":"10.1097","volume":"13","author":[{"given":"Lars H.","family":"Lindholm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004872-199512002-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:01:09Z","timestamp":1785862869000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004872-199512002-00002"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[1995,12]]},"references-count":0,"journal-issue":{"issue":"supplement4"},"URL":"https:\/\/doi.org\/10.1097\/00004872-199512002-00002","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[1995,12]]}}}